May 29, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on June 9 whether to recommend approval for Biogen Japan’s spinal muscular atrophy (SMA) treatment nusinersen. The Pharmaceutical Affairs and Food Sanitation Council’s First Committee...read more